Cardio Diagnostics Holdings - $CDIO
7 months ago
Stock Pursuit
"CDIO: Epigenetic heart test co. trading at $6.9M mkt cap vs $8.7M net cash, no LT debt. 3 tests (Epi+Gen CHD, Precision CHD, ACI) address $8.5B market. AI-driven tech outperforms traditional tests. Revenue +100% YoY but still tiny ($34.8K). New sales team, 7 new practices signed. Acquisition potential from Quest/LabCorp/Roche."
Sentiment
bullish
Conviction
Medium
Tier
Trade Call
Related Stocks
Episode Information
Episode:
Cardio Diagnostics Holdings - $CDIO
Source:
Stock Pursuit
Published:
June 2, 2025
Idea Type:
Stock Idea